Eelkema J A, O'Donnell M A, Brooker R J
Department of Genetics and Cell Biology, University of Minnesota, St. Paul 55108.
J Biol Chem. 1991 Mar 5;266(7):4139-44.
The double mutant of the lactose permease containing Val177/Asn319 exhibits proton leakiness by two pathways (see Brooker, R. J. (1991) J. Biol Chem. 266, 4131-4138). One type of H+ leakiness involves the uncoupled influx of H+ (leak A pathway) while a second type involves the coupled influx of H+ and galactosides in conjunction with uncoupled galactoside efflux (leak B pathway). In the current study, 14 independent lactose permease mutants were isolated from the Val177/Asn319 parent which were resistant to thiodigalactoside growth inhibition but retained the ability to transport maltose. All of these mutants contained a third mutation (besides Val177/Asn319) at one of two sites. Eight of the mutants had Ile303 changed to Phe, while six of the mutants had Tyr236 changed to Asn or His. Each type of triple mutant was characterized with regard to sugar transport, H+ leakiness, and sugar specificity. Like the parental strain, all three types of triple mutant showed moderate rates of downhill lactose transport and were defective in the uphill accumulation of sugars. However, with regard to proton leakiness, the triple mutants fell into two distinct categories. The mutant containing Phe303 was generally less H+ leaky than the parent either via the leak A or leak B pathway. In contrast, the triple mutants containing position 236 substitutions (Asn or His) were actually more H+ leaky via the leak A pathway and exhibited similar H+ leakiness via the leak B pathway at high thiodigalactoside concentrations. The ability of the position 236 mutants to grow better than the parent in the presence of low concentrations of thiodigalactoside appears to be due to a decrease in affinity for this particular sugar rather than a generalized defect in H+ leakiness. Finally, the triple mutants showed a sugar specificity profile which was different from either the Val177/Asn319 parent, the single Val177 mutant, or the wild-type strain. These results are discussed with regard to the effects of mutations on both the sugar and H+ transport pathways.
含有Val177/Asn319的乳糖通透酶双突变体通过两条途径表现出质子渗漏(见布鲁克,R.J.(1991年)《生物化学杂志》266卷,4131 - 4138页)。一种类型的H⁺渗漏涉及H⁺的非偶联内流(渗漏A途径),而第二种类型涉及H⁺与半乳糖苷的偶联内流以及半乳糖苷的非偶联外流(渗漏B途径)。在当前研究中,从Val177/Asn319亲本中分离出14个独立的乳糖通透酶突变体,它们对硫代二半乳糖苷生长抑制具有抗性,但保留了转运麦芽糖的能力。所有这些突变体在两个位点之一含有第三个突变(除了Val177/Asn319)。其中8个突变体的Ile303变为Phe,而6个突变体的Tyr236变为Asn或His。对每种类型的三重突变体在糖转运、H⁺渗漏和糖特异性方面进行了表征。与亲本菌株一样,所有三种类型的三重突变体都显示出适度的下坡乳糖转运速率,并且在糖的上坡积累方面存在缺陷。然而,关于质子渗漏,三重突变体分为两个不同的类别。含有Phe303的突变体通过渗漏A或渗漏B途径的H⁺渗漏通常比亲本少。相比之下,含有236位取代(Asn或His)的三重突变体通过渗漏A途径实际上具有更多的H⁺渗漏,并且在高硫代二半乳糖苷浓度下通过渗漏B途径表现出相似的H⁺渗漏。236位突变体在低浓度硫代二半乳糖苷存在下比亲本生长更好的能力似乎是由于对这种特定糖的亲和力降低,而不是H⁺渗漏的普遍缺陷。最后,三重突变体显示出与Val177/Asn319亲本、单个Val177突变体或野生型菌株不同的糖特异性谱。讨论了这些结果关于突变对糖和H⁺转运途径的影响。